NHC Reports Third Quarter 2023 Earnings
- Net operating revenues and grant income for NHC increased by 6.5% to $288,485,000 for the quarter ended September 30, 2023.
- Same-facility net operating revenues saw a significant increase of 11.8% during the third quarter of 2023 compared to the same period in 2022.
- GAAP net income attributable to NHC was $10,388,000 for the quarter, a positive turnaround from a net loss of $2,429,000 in 2022.
- Adjusted net income for the quarter reached $13,250,000, showing growth from $7,783,000 in 2022.
- The increase in earnings was driven by higher occupancy rates in skilled nursing and assisted living facilities, per diem increases from government payors, and reduced nurse agency staffing expenses.
- None.
For the quarter ended September 30, 2023, the reported GAAP net income attributable to NHC was
(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.
About NHC
NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,732 beds. NHC affiliates also operate 26 assisted living communities with 1,501 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 30 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.
Consolidated Statements of Operations | ||||||||||||||||
(in thousands, except share and per share amounts) | ||||||||||||||||
Three Months Ended |
|
Nine Months Ended |
||||||||||||||
September 30 |
|
September 30 |
||||||||||||||
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
||
(unaudited) |
|
(unaudited) |
||||||||||||||
Revenues and grant income: | ||||||||||||||||
Net patient revenues | $ |
277,005 |
|
$ |
260,247 |
|
$ |
804,617 |
|
$ |
776,661 |
|
||||
Other revenues |
|
11,480 |
|
|
10,596 |
|
|
36,013 |
|
|
33,584 |
|
||||
Government stimulus income |
|
- |
|
|
- |
|
|
- |
|
|
10,940 |
|
||||
Net operating revenues and grant income |
|
288,485 |
|
|
270,843 |
|
|
840,630 |
|
|
821,185 |
|
||||
Costs and expenses: | ||||||||||||||||
Salaries, wages and benefits |
|
182,664 |
|
|
173,198 |
|
|
525,782 |
|
|
518,828 |
|
||||
Other operating |
|
72,490 |
|
|
72,883 |
|
|
217,213 |
|
|
218,279 |
|
||||
Facility rent |
|
10,094 |
|
|
10,294 |
|
|
30,087 |
|
|
30,770 |
|
||||
Depreciation and amortization |
|
10,135 |
|
|
10,253 |
|
|
30,266 |
|
|
30,011 |
|
||||
Interest |
|
77 |
|
|
137 |
|
|
268 |
|
|
451 |
|
||||
Total costs and expenses |
|
275,460 |
|
|
266,765 |
|
|
803,616 |
|
|
798,339 |
|
||||
Income from operations |
|
13,025 |
|
|
4,078 |
|
|
37,014 |
|
|
22,846 |
|
||||
Non-operating income |
|
4,097 |
|
|
2,731 |
|
|
12,116 |
|
|
8,451 |
|
||||
Unrealized gains/(losses) on marketable equity securities |
|
(3,093 |
) |
|
(11,056 |
) |
|
2,943 |
|
|
(11,479 |
) |
||||
Income/(loss) before income taxes |
|
14,029 |
|
|
(4,247 |
) |
|
52,073 |
|
|
19,818 |
|
||||
Income tax (provision)/benefit |
|
(3,908 |
) |
|
1,140 |
|
|
(14,750 |
) |
|
(5,415 |
) |
||||
Net income/(loss) |
|
10,121 |
|
|
(3,107 |
) |
|
37,323 |
|
|
14,403 |
|
||||
Net loss attributable to noncontrolling interest |
|
267 |
|
|
678 |
|
|
1,069 |
|
|
1,689 |
|
||||
Net income/(loss) attributable to National HealthCare Corporation | $ |
10,388 |
|
$ |
(2,429 |
) |
$ |
38,392 |
|
$ |
16,092 |
|
||||
Net income/(loss) per common share | ||||||||||||||||
Basic | $ |
0.68 |
|
$ |
(0.16 |
) |
$ |
2.51 |
|
$ |
1.04 |
|
||||
Diluted | $ |
0.68 |
|
$ |
(0.16 |
) |
$ |
2.50 |
|
$ |
1.04 |
|
||||
Weighted average common shares outstanding | ||||||||||||||||
Basic |
|
15,299,913 |
|
|
15,445,569 |
|
|
15,311,453 |
|
|
15,438,375 |
|
||||
Diluted |
|
15,324,511 |
|
|
15,445,569 |
|
|
15,334,269 |
|
|
15,477,103 |
|
||||
Dividends declared per common share | $ |
0.59 |
|
$ |
0.57 |
|
$ |
1.75 |
|
$ |
1.69 |
|
||||
Balance Sheet Data | September 30 |
December 31 |
||||||||||||||
(in thousands) |
|
2023 |
|
|
2022 |
|
||||||||||
(unaudited) |
||||||||||||||||
Cash, cash equivalents and marketable securities | $ |
210,494 |
|
$ |
182,589 |
|
||||||||||
Restricted cash, cash equivalents and marketable securities |
|
162,492 |
|
|
158,067 |
|
||||||||||
Current assets |
|
382,578 |
|
|
353,932 |
|
||||||||||
Property and equipment, net |
|
498,266 |
|
|
506,532 |
|
||||||||||
Total assets |
|
1,281,907 |
|
|
1,275,450 |
|
||||||||||
Current liabilities |
|
204,694 |
|
|
197,887 |
|
||||||||||
Stockholders' equity |
|
887,340 |
|
|
877,514 |
|
||||||||||
Selected Operating Statistics | |||||||||||||
Three Months Ended |
|
Nine Months Ended |
|||||||||||
September 30 |
|
September 30 |
|||||||||||
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|||
(unaudited) |
|
(unaudited) |
|||||||||||
Skilled Nursing Per Diems: | |||||||||||||
Medicare | $ |
551.82 |
$ |
535.60 |
$ |
552.21 |
$ |
540.30 |
|||||
Managed Care |
|
489.18 |
|
429.22 |
|
460.20 |
|
425.39 |
|||||
Medicaid |
|
256.46 |
|
237.61 |
|
248.99 |
|
230.79 |
|||||
Private Pay and Other |
|
283.49 |
|
265.68 |
|
279.12 |
|
268.13 |
|
||||
Average Skilled Nursing Per Diem | $ |
325.34 |
$ |
302.43 |
(1) |
$ |
320.09 |
$ |
301.91 |
(1) |
|||
Skilled Nursing Patient Days: | |||||||||||||
Medicare |
|
75,215 |
|
81,940 |
|
239,228 |
|
258,961 |
|||||
Managed Care |
|
61,979 |
|
52,956 |
|
179,992 |
|
163,823 |
|||||
Medicaid |
|
290,887 |
|
302,500 |
|
852,074 |
|
919,931 |
|||||
Private Pay and Other |
|
170,857 |
|
169,068 |
|
492,279 |
|
489,477 |
|||||
Total Skilled Nursing Patient Days |
|
598,938 |
|
606,464 |
(1) |
|
1,763,573 |
|
1,832,192 |
(1) |
|||
(1) For the three and nine months ended September 30, 2022, the skilled nursing per diems and patient days listed above include the seven skilled nursing facilities that were located in |
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): | ||||||||||||||||
Three Months Ended |
|
Nine Months Ended |
||||||||||||||
September 30 |
|
September 30 |
||||||||||||||
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
||
(unaudited) |
|
(unaudited) |
||||||||||||||
Net income/(loss) attributable to National Healthcare Corporation | $ |
10,388 |
|
$ |
(2,429 |
) |
$ |
38,392 |
|
$ |
16,092 |
|
||||
Non-GAAP adjustments | ||||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
3,093 |
|
|
11,056 |
|
|
(2,943 |
) |
|
11,479 |
|
||||
Operating results for newly opened operations not at full capacity (2) |
|
66 |
|
|
2,105 |
|
|
1,616 |
|
|
4,033 |
|
||||
Stock-based compensation expense |
|
708 |
|
|
639 |
|
|
2,119 |
|
|
1,980 |
|
||||
Income tax (benefit)/provision on non-GAAP adjustments |
|
(1,005 |
) |
|
(3,588 |
) |
|
(206 |
) |
|
(4,548 |
) |
||||
Non-GAAP Net income | $ |
13,250 |
|
$ |
7,783 |
|
$ |
38,978 |
|
$ |
29,036 |
|
||||
GAAP diluted earnings/(loss) per share | $ |
0.68 |
|
$ |
(0.16 |
) |
$ |
2.51 |
|
$ |
1.04 |
|
||||
Non-GAAP adjustments | ||||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
0.15 |
|
|
0.53 |
|
|
(0.14 |
) |
|
0.56 |
|
||||
Operating results for newly opened operations not at full capacity (2) |
|
- |
|
|
0.10 |
|
|
0.07 |
|
|
0.19 |
|
||||
Stock-based compensation expense |
|
0.03 |
|
|
0.03 |
|
|
0.10 |
|
|
0.09 |
|
||||
Non-GAAP diluted earnings per share | $ |
0.86 |
|
$ |
0.50 |
|
$ |
2.54 |
|
$ |
1.88 |
|
||||
(2) The newly opened operations not at full capacity for the 2023 periods presented consisted of operations opened from 2021 through 2023. This consisted of two behavioral health hospitals, two homecare agencies, and two hospice agencies. The newly opened operations for the 2022 periods presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20231103999819/en/
Brian F. Kidd, SVP/Chief Financial Officer
Phone: (615) 890-2020
Source: National HealthCare Corporation
FAQ
What are the net operating revenues and grant income reported by National HealthCare Corporation (NHC) for the quarter ended September 30, 2023?
How much did same-facility net operating revenues increase during the third quarter of 2023 compared to the same period in 2022?
What was the net income attributable to NHC for the quarter ended September 30, 2023?
How does the adjusted net income for the quarter ended September 30, 2023 compare to the same period in 2022?